title: Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence.
authors.affiliation: Clinical Pharmacokinetics Unit, Medical Intensive Care Research Laboratory, and Intensive Care Unit, Department of Internal Medicine, University of Innsbruck, Austria. romuald.bellmann@uibk.ac.at
authors.forename: Romuald
authors.initials: R
authors.lastname: Bellmann
authors.forename: Petra
authors.initials: P
authors.lastname: Egger
authors.forename: Christian J
authors.initials: CJ
authors.lastname: Wiedermann
mesh_terms: D000666:Amphotericin B / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002626:Chemistry, Pharmaceutical; D004337:Drug Carriers; D006801:Humans; D050356:Lipid Metabolism; D008081:Liposomes; D009181:Mycoses / Q000378:metabolism*
chemical_list: D000935:Antifungal Agents; D004337:Drug Carriers; D008081:Liposomes; D000666:Amphotericin B